Patent: 9,969,786
✉ Email this page to a colleague
Summary for Patent: 9,969,786
Title: | Trophic hormone fusion protein, preparation method and application thereof |
Abstract: | Disclosed herein is a gonadotropin fusion protein or a thyroid stimulating hormone fusion protein, a method for preparing the same and use thereof. .beta.-subunit of the gonadotropin or thyroid stimulating hormone is fused to an Fc fragment directly or indirectly through a linker, and .alpha.-subunit binds to the .beta.-subunit via an affinity between the .alpha.-subunit and the .beta.-subunit. The fusion protein has a prolonged half-life and less fluctuating activity. |
Inventor(s): | Xu; Ting (Jiangsu, CN), Guo; Kangping (Jiangsu, CN), Yun; Lihong (Jiangsu, CN) |
Assignee: | Suzhou Alphamab Co, Ltd. (Suzhou Jiangsu, CN) |
Application Number: | 14/646,926 |
Patent Claims: | see list of patent claims |
Details for Patent 9,969,786
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Ferring Pharmaceuticals Inc. | NOVAREL | chorionic gonadotropin | For Injection | 017016 | 01/15/1974 | ⤷ Try a Trial | 2032-11-22 |
Ferring Pharmaceuticals Inc. | NOVAREL | chorionic gonadotropin | For Injection | 017016 | 12/27/1984 | ⤷ Try a Trial | 2032-11-22 |
Ferring Pharmaceuticals Inc. | NOVAREL | chorionic gonadotropin | For Injection | 017016 | 02/15/1985 | ⤷ Try a Trial | 2032-11-22 |
Ferring Pharmaceuticals Inc. | NOVAREL | chorionic gonadotropin | For Injection | 017016 | 02/16/1990 | ⤷ Try a Trial | 2032-11-22 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |